FROM THE ARCHIVES: Fighting HIV In 2003

By Worldview Staff
School students interact as they participate in a ‘Walk For Life’ event, on the eve of World AIDS Day, in New Delhi, India, Sunday, Nov. 30, 2003. The event was an attempt to create awareness on the stigma and discrimination faced by HIV affected people
School students interact as they participate in a 'Walk For Life' event, on the eve of World AIDS Day, in New Delhi, India, Sunday, Nov. 30, 2003. The event was an attempt to create awareness on the stigma and discrimination faced by HIV affected people Gurinder Osan / AP Photo
School students interact as they participate in a ‘Walk For Life’ event, on the eve of World AIDS Day, in New Delhi, India, Sunday, Nov. 30, 2003. The event was an attempt to create awareness on the stigma and discrimination faced by HIV affected people
School students interact as they participate in a 'Walk For Life' event, on the eve of World AIDS Day, in New Delhi, India, Sunday, Nov. 30, 2003. The event was an attempt to create awareness on the stigma and discrimination faced by HIV affected people Gurinder Osan / AP Photo

FROM THE ARCHIVES: Fighting HIV In 2003

By Worldview Staff
WBEZ brings you fact-based news and information. Sign up for our newsletters to stay up to date on the stories that matter.

In 2003, VaxGen, a San Francisco-based biotechnology company, announced that its AIDSVAX vaccine trial had not reduced HIV infection rates among those who were vaccinated. On April 4 of that year, Worldview spoke to Bob Elliot, a college student who co-founded the Student Global AIDS Campaign. The Campaign still exists and last year launched a campaign called “PrEP for the Future,” which aims to increase the accessibility of pre-exposure prophylaxis. They also advocate for the U.S. to increase its funding contribution to the AIDS programs PEPFAR and the Global Fund.

Special thanks to the WBEZ Archives Team for cataloging 25 years of Worldview and making this segment possible.